No Data
No Data
Canaan Technology (300412.SZ): Net loss of 5.9875 million yuan in the first quarter
Gelonghui, April 26 | Canaan Technology (300412.SZ) released its report for the first quarter of 2024. Operating revenue for the reporting period was 219 million yuan, up 9.54% year on year; net profit attributable to shareholders of listed companies - 5.9875 million yuan, year-on-year profit and loss; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss - 6.6538 million yuan; basic earnings per share - 0.01 yuan.
Canaan Technology (300412.SZ): net loss of 23.43 million yuan in 2023, year-on-year loss reduction
Glonghui, April 19 | Canaan Technology (300412.SZ) released its 2023 annual report. Operating income was 1,047 million yuan, down 5.11% year on year, net loss of 23.43 million yuan, year-on-year loss reduced. After deducting non-net loss of 37.67 million yuan, year-on-year loss reduction, with basic earnings per share -0.05 yuan.
Canaan Technology (300412.SZ): Plans to reform the shareholding subsidiary Shanghai Kaixian and apply for listing on the New Third Board
Gelonghui, March 28 | Canaan Technology (300412.SZ) announced that the company's holding subsidiary Shanghai Kaixian Fluid Technology Co., Ltd. (“Shanghai Kaixian”) plans to restructure and establish a limited company in order to seize capital market development opportunities, increase sustainable development capabilities, and further improve the standardized operation level of the enterprise, and apply for listing in the national SME share transfer system (“New Third Board” for short) in accordance with relevant national laws, regulations, policies and conditions.
Canaan Technology (300412.SZ): The main business is pharmaceutical equipment, and it is a well-known domestic supplier of integrated solutions for smart solid preparation factories
Gelonghui March 22丨Canaan Technology (300412.SZ) said on the investor interactive platform that the company's main business is pharmaceutical equipment and is a well-known domestic supplier of integrated solutions for smart solid pharmaceutical factories. The company's specific business segments can be subdivided into oral solid preparation equipment and smart factory business, biological and sterile preparation water equipment and dispensing system engineering business, smart logistics business, pharmaceutical R&D services, etc.; the products mainly include powder process equipment, solid preparation equipment, traditional Chinese medicine extraction equipment, fluid process equipment, intelligent logistics systems, pharmaceutical R&D consistency evaluation and testing services, etc.
Canaan Technology (300412.SZ): Committed to providing global pharmaceutical customers with integrated automated, intelligent and information-based solutions
Gelonghui March 11 | Canaan Technology (300412.SZ) said on the investor interactive platform that Zhejiang Wantu Sirui Robotics Co., Ltd., the holding company established by the company in November 2022, mainly operates in the intelligent robot business, and the company will rationally plan R&D and investment according to market development and business needs. The company has always maintained its focus on cutting-edge technologies such as artificial intelligence and robotics, hoping to use new technology to explore new scenarios, continuously optimize product systems, and enhance product competitiveness. The company is committed to providing global pharmaceutical customers with integrated automated, intelligent and information-based solutions.
Zhejiang Canaan Technology Limited (SZSE:300412) Surges 42% Yet Its Low P/S Is No Reason For Excitement
Those holding Zhejiang Canaan Technology Limited (SZSE:300412) shares would be relieved that the share price has rebounded 42% in the last thirty days, but it needs to keep going to repair the recent
No Data